Advertisement
Study findings warrant caution in patients at risk for DVT, cardiovascular issues and more
Survey suggests need for evidence-based education among patients and providers alike
Cannabinoid oromucosal spray is poised for FDA submission in 2021
Any benefits are inconclusive while harms are well established
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Advertisement
Advertisement